Chemoinformaics analysis of Trans-P-Mentha-1(10),5,Diene-2-Ol
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -1.93 | nHRing | 0 |
| Solubility: LogP | 2.009 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.61 |
| Synth | 4.257 |
| Natural Product Likeliness | 3.421 |
| NR-PPAR-gamma | 0.064 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -4.508 |
| MDCK | 0.0000259 |
| BBB | 0.987 |
| PPB | 0.524756 |
| VDSS | 1.206 |
| FU | 0.380318 |
| CYP1A2-inh | 0.074 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.822 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.423 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.241 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.392 |
| CL | 12.728 |
| T12 | 0.563 |
| hERG | 0.024 |
| Ames | 0.139 |
| ROA | 0.422 |
| SkinSen | 0.866 |
| Carcinogencity | 0.876 |
| EI | 0.79 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.90833 |